Literature DB >> 19870779

AN UNIDENTIFIED VIRUS PRODUCING ACUTE MENINGITIS AND PNEUMONITIS IN EXPERIMENTAL ANIMALS.

T Francis1, T P Magill.   

Abstract

An infectious agent is described which belongs apparently to the class of filtrable viruses, but which, on the basis of the evidence at hand, is not to be identified with any virus previously described. The virus has multiple tropisms and is pathogenic for mice, ferrets, and monkeys of both M. rhesus and M. cynomolgos species. Intranasal infection of mice and ferrets causes extensive pneumonic lesions of fatal severity. Intracerebral inoculation of the virus produces in monkeys a lymphocytic choriomeningitis from which the animal recovers, while in mice a rapidly fatal choriomeningitis is produced. Fatal paralysis occurs in a moderate proportion of mice which receive the virus by intraperitoneal or subcutaneous routes, while the remainder become immune to the intracerebral test but not to the intranasal test. Subcutaneous inoculation of mice, monkeys, ferrets, rabbits, and guinea pigs causes local granulomatous induration of the skin with enlargement of the regional lymph nodes. The virus was repeatedly recovered in 1936 from ferrets inoculated with throat washings of patients suffering from an epidemic disease clinically indistinguishable from epidemic influenza. It is impossible, however, to conclude whether the virus is of ferret or human origin. Although possessing many features in common with the virus of lymphocytic choriomeningitis and the virus of lymphogranuloma inguinale, cross immunity tests have failed to yield any evidence that the new agent is immunologically related to either of the aforementioned viruses. For purposes of identification the name virus of acute meningopneumonitis is suggested.

Entities:  

Year:  1938        PMID: 19870779      PMCID: PMC2133670          DOI: 10.1084/jem.68.2.147

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  TRANSMISSION OF INFLUENZA BY A FILTERABLE VIRUS.

Authors:  T Francis
Journal:  Science       Date:  1934-11-16       Impact factor: 47.728

2.  Etiological and Serological Studies in Epidemic Influenza.

Authors:  T Francis; T P Magill; E R Rickard; M D Beck
Journal:  Am J Public Health Nations Health       Date:  1937-11

3.  MENINGITIS IN MAN CAUSED BY A FILTERABLE VIRUS : II. IDENTIFICATION OF THE ETIOLOGICAL AGENT.

Authors:  T M Rivers; T F Scott
Journal:  J Exp Med       Date:  1936-02-29       Impact factor: 14.307

4.  PSITTACOSIS : IV. EXPERIMENTALLY INDUCED INFECTIONS IN MONKEYS.

Authors:  T M Rivers; G P Berry
Journal:  J Exp Med       Date:  1931-06-30       Impact factor: 14.307

5.  PSITTACOSIS : III. EXPERIMENTALLY INDUCED INFECTIONS IN RABBITS AND GUINEA PIGS.

Authors:  T M Rivers; G P Berry
Journal:  J Exp Med       Date:  1931-06-30       Impact factor: 14.307

6.  RIFT VALLEY FEVER : A REPORT OF THREE CASES OF LABORATORY INFECTION AND THE EXPERIMENTAL TRANSMISSION OF THE DISEASE TO FERRETS.

Authors:  T Francis; T P Magill
Journal:  J Exp Med       Date:  1935-08-31       Impact factor: 14.307

7.  THE INFECTION OF FERRETS WITH SWINE INFLUENZA VIRUS.

Authors:  R E Shope
Journal:  J Exp Med       Date:  1934-06-30       Impact factor: 14.307

8.  SPONTANEOUS ENCEPHALOMYELITIS OF MICE, A NEW VIRUS DISEASE.

Authors:  M Theiler
Journal:  J Exp Med       Date:  1937-04-30       Impact factor: 14.307

9.  PSITTACOSIS : II. EXPERIMENTALLY INDUCED INFECTIONS IN MICE.

Authors:  T M Rivers; G P Berry
Journal:  J Exp Med       Date:  1931-06-30       Impact factor: 14.307

10.  AN EPIDEMIC IN A MOUSE COLONY DUE TO THE VIRUS OF ACUTE LYMPHOCYTIC CHORIOMENINGITIS.

Authors:  E Traub
Journal:  J Exp Med       Date:  1936-03-31       Impact factor: 14.307

  10 in total
  24 in total

1.  Studies on primary atypical pneumonia virus.

Authors:  S ARAKAWA; N GOTO; T KANEKO; I KONDO
Journal:  Arch Gesamte Virusforsch       Date:  1956

2.  Sequencing of the Chlamydophila psittaci ompA gene reveals a new genotype, E/B, and the need for a rapid discriminatory genotyping method.

Authors:  Tom Geens; Ann Desplanques; Marnix Van Loock; Brigitte M Bönner; Erhard F Kaleta; Simone Magnino; Arthur A Andersen; Karin D E Everett; Daisy Vanrompay
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  [Etiologic studies of a benign epidemic meningitis].

Authors:  K F BINGEL
Journal:  Z Hyg Infektionskr       Date:  1951

4.  Feline Virus Pneumonia and Its Possible Relation to Some Cases of Primary Atypical Pneumonia in Man.

Authors:  F G Blake; M E Howard; H Tatlock
Journal:  Yale J Biol Med       Date:  1942-12

5.  Growth of Chlamydia psittaci strain meningopneumonitis in mouse L cells cultivated in a defined medium in spinner cultures.

Authors:  S J Morrison; H M Jenkin
Journal:  In Vitro       Date:  1972 Sep-Oct

6.  Genome sequences of the zoonotic pathogens Chlamydia psittaci 6BC and Cal10.

Authors:  Valerie Grinblat-Huse; Elliott F Drabek; Heather Huot Creasy; Sean C Daugherty; Kristine M Jones; Ivette Santana-Cruz; Luke J Tallon; Timothy D Read; Thomas P Hatch; Patrik Bavoil; Garry S A Myers
Journal:  J Bacteriol       Date:  2011-05-27       Impact factor: 3.490

7.  Molecular characterization of a bacteriophage (Chp2) from Chlamydia psittaci.

Authors:  B L Liu; J S Everson; B Fane; P Giannikopoulou; E Vretou; P R Lambden; I N Clarke
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Some general remarks and new observations on psittacosis and ornithosis.

Authors:  K F MEYER
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

9.  Isolation, molecular characterisation and genome sequence of a bacteriophage (Chp3) from Chlamydophila pecorum.

Authors:  Sarah A Garner; J Sylvia Everson; Paul R Lambden; Bentley A Fane; Ian N Clarke
Journal:  Virus Genes       Date:  2004-03       Impact factor: 2.332

10.  Host range of chlamydiaphages phiCPAR39 and Chp3.

Authors:  J S Everson; S A Garner; P R Lambden; B A Fane; I N Clarke
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.